PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody Molecules

被引：0
|
作者：
Shibo Qi
Susan Hoppmann
Yingding Xu
Zhen Cheng
机构：
[1] Tianjin Polytechnic University,School of Environmental and Chemical Engineering
[2] Stanford University,Molecular Imaging Program at Stanford (MIPS), Department of Radiology, and Bio
来源：
Molecular Imaging and Biology | 2019年 / 21卷
关键词：
PET; Affibody; HER2; Cu-64; Tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：907 / 916
页数：9
相关论文
共 50 条
  • [21] PET imaging of 89Zr-labeled Pertuzumab in HER2-positive breast cancer xenografts
    Marquez, Bernadette V.
    Ikotun, Oluwatayo F.
    Wright, Brian
    Zheleznyak, Alexander
    Richard, Pierce
    Lapi, Suzanne E.
    CANCER RESEARCH, 2014, 74 (19)
  • [22] Cu-64-labeled BAT-21T-NR-LU-10 Fab: An agent for PET imaging and radioimmunotherapy
    Anderson, CJ
    Connett, JM
    Germain, CJ
    Guo, LW
    Rogers, BE
    Schwarz, SW
    Fritzberg, AR
    Welch, MJ
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 371 - 371
  • [23] Initial results with PET imaging using Cu-64-labeled teta-octreotide in patients with carcinoid tumor.
    Dehdashti, F
    Anderson, CJ
    Trask, DD
    Bass, LA
    Schwarz, SW
    Cutler, PD
    McCarthy, DW
    Lanahan, MV
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 381 - 381
  • [24] PET Imaging of HER2 Expressing Tumors using a Novel 18F labeled Affibody with a Hydrophilic Linker
    Yang, M.
    Xu, Y.
    Bai, Z.
    Pan, D.
    Wang, L.
    Yan, J.
    Yang, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S236 - S236
  • [25] Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Positive Tumor with a 64Cu Labeled Affibody Protein
    Miao, Zheng
    Ren, Gang
    Liu, Hongguang
    Jiang, Lei
    Cheng, Zhen
    BIOCONJUGATE CHEMISTRY, 2010, 21 (05) : 947 - 954
  • [26] Longitudinal analysis of PET imaging with Cu-64-labeled collagen specific peptides for the detection of collagen in myocardial fibrosis in rats
    Kim, Jin Su
    Kim, Insook
    Lee, Sung-Jin
    Kim, Heejung
    Davies-Venn, Cynthia
    Won, Samuel
    Niu, Gang
    Chen, Xiaoyuan
    Paik, Chang
    Bluemke, David
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [27] IN VITRO AND IN VIVO EVALUATION OF STRUCTURALLY DIVERSE CU-64-LABELED RGD PEPTIDES FOR PET IMAGING OF αVβ3 EXPRESSION
    Fiamengo, A. L.
    Ye, Y.
    Achilefu, S.
    Anderson, C. J.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S33 - S33
  • [28] Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific affibody molecule
    Tolmachev, Vladimir
    Orlova, Anna
    Pehrson, Rikard
    Galli, Joakim
    Baastrup, Barbro
    Andersson, Karl
    Sandstrom, Mattias
    Rosik, Daniel
    Carlsson, Jorgen
    Lundqvist, Hans
    Wennborg, Anders
    Nilsson, Fredrik Y.
    CANCER RESEARCH, 2007, 67 (06) : 2773 - 2782
  • [29] EVALUATION OF A Cu-64-LABELED SarAr CONJUGATED BOMBESIN ANALOG FOR DETECTION OF GASTRIN-RELEASING PEPTIDE RECEPTOR POSITIVE TUMORS
    Kelly, T. S.
    Ferdani, R.
    Liang, K.
    Andrews, R.
    Sherman, C. D.
    Achilefu, S.
    Anderson, C. J.
    Rogers, B. E.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S352 - S352
  • [30] 64Cu DOTA-trastuzumab (64Cu-Herceptin)/PET effectively visualizes metastatic breast cancer in HER2-positive patients
    Bading, J.
    Conti, Peter
    Tong, Shan
    Reyes, J.
    Carroll, Mary
    Poku, Erasmus
    Miles, Joshua
    Colcher, David
    Raubitschek, Andrew
    Mortimer, Joanne
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345